Literature DB >> 9605926

Agonist-induced phosphorylation of the endogenous AT1 angiotensin receptor in bovine adrenal glomerulosa cells.

R D Smith1, A J Baukal, A Zolyomi, Z Gaborik, L Hunyady, L Sun, M Zhang, H C Chen, K J Catt.   

Abstract

A polyclonal antibody was raised in rabbits against a fusion protein immunogen consisting of bacterial maltose-binding protein coupled to a 92-amino acid C-terminal fragment of the rat AT1b angiotensin II (Ang II) receptor. The antibody immunoprecipitated the photoaffinity-labeled bovine AT1 receptor (AT1-R), but not the rat AT2 receptor, and specifically stained bovine adrenal glomerulosa cells and AT1a receptor-expressing Cos-7 cells, as well as the rat adrenal zona glomerulosa and renal glomeruli. The antibody was employed to analyze Ang II-induced phosphorylation of the endogenous AT1-R immunoprecipitated from cultured bovine adrenal glomerulosa cells. Receptor phosphorylation was rapid, sustained for up to 60 min, and enhanced by pretreatment of the cells with okadaic acid. Its magnitude was correlated with the degree of ligand occupancy of the receptor. Activation of protein kinase A and protein kinase C (PKC) also caused phosphorylation of the receptor, but to a lesser extent than Ang II. Inhibition of PKC by staurosporine augmented Ang II-stimulated AT1-R phosphorylation, suggesting a negative regulatory role of PKC on the putative G protein-coupled receptor kinase(s) that mediates the majority of AT1-R phosphorylation. The antibody should permit further analysis of endogenous AT1-R phosphorylation in Ang II target cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605926     DOI: 10.1210/mend.12.5.0108

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  7 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  S-nitrosylation of cysteine 289 of the AT1 receptor decreases its binding affinity for angiotensin II.

Authors:  Patrice C Leclerc; Pascal M Lanctot; Mannix Auger-Messier; Emanuel Escher; Richard Leduc; Gaetan Guillemette
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

3.  Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor.

Authors:  H Qian; L Pipolo; W G Thomas
Journal:  Biochem J       Date:  1999-11-01       Impact factor: 3.857

4.  Demonstration of angiotensin II-induced Ras activation in the trans-Golgi network and endoplasmic reticulum using bioluminescence resonance energy transfer-based biosensors.

Authors:  András Balla; László Sándor Erdélyi; Eszter Soltész-Katona; Tamas Balla; Péter Várnai; László Hunyady
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

5.  Heterologous desensitization of the sphingosine-1-phosphate receptors by purinoceptor activation in renal mesangial cells.

Authors:  Cuiyan Xin; Shuyu Ren; Josef Pfeilschifter; Andrea Huwiler
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

6.  Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes.

Authors:  Shuya Wang; Ying Li; Wei Miao; Hong Zhao; Feng Zhang; Nan Liu; Guohai Su; Xiaojun Cai
Journal:  Mol Med Rep       Date:  2016-07-25       Impact factor: 2.952

7.  The Expression of MTUS1/ATIP and Its Major Isoforms, ATIP1 and ATIP3, in Human Prostate Cancer.

Authors:  Simon N S Louis; Laurie T C Chow; Naghmeh Varghayee; Linda A Rezmann; Albert G Frauman; William J Louis
Journal:  Cancers (Basel)       Date:  2011-10-11       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.